Adherence with tobramycin inhaled solution and health care utilization
Open Access
- 20 January 2011
- journal article
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 11 (1) , 5
Abstract
Adherence with tobramycin inhalation solution (TIS) during routine cystic fibrosis (CF) care may differ from recommended guidelines and affect health care utilization.Keywords
This publication has 17 references indexed in Scilit:
- Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosisJournal of Cystic Fibrosis, 2009
- Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes.2005
- Specificity and Sensitivity of Claims‐Based Algorithms for Identifying Members of Medicare+Choice Health Plans That Have Chronic Medical ConditionsHealth Services Research, 2004
- Variations in Patients’ Adherence to Medical RecommendationsMedical Care, 2004
- Cystic Fibrosis Adult CareChest, 2004
- A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosisHealth Technology Assessment, 2002
- Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosisPediatric Pulmonology, 2002
- Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosisThe Journal of Pediatrics, 2001
- Validation of Patient Reports, Automated Pharmacy Records, and Pill Counts With Electronic Monitoring of Adherence to Antihypertensive TherapyMedical Care, 1999
- Intermittent Administration of Inhaled Tobramycin in Patients with Cystic FibrosisNew England Journal of Medicine, 1999